Search results
Results from the WOW.Com Content Network
The Beers Criteria for Potentially Inappropriate Medication Use in Older Adults, commonly called the Beers List, [1] are guidelines published by the American Geriatrics Society (AGS) for healthcare professionals to help improve the safety of prescribing medications for adults 65 years and older in all except palliative settings.
Mark Howard Beers (April 24, 1954 – February 28, 2009) [1] was an American geriatrician whose research on drug interactions among the elderly led to the creation of the eponymous Beers criteria, which lists prescription medications that may have deleterious side effects in older patients.
The Beers Criteria and the STOPP/START criteria present medications that may be inappropriate for use in older adults, [31] including drugs associated with high risk of adverse reactions for this population or lacking evidence for their benefits when safer and more effective alternatives exist. [32]
The use of polypharmacy is correlated to the use of potentially inappropriate medications. Potentially inappropriate medications are generally taken to mean those that have been agreed upon by expert consensus, such as by the Beers Criteria. These medications are generally inappropriate for older adults because the risks outweigh the benefits. [37]
Finally, note that the benzodiazepine core is a privileged scaffold, which has been used to derive drugs with diverse activity that is not limited to the GABA A modulatory action of the classical benzodiazepines, [60] such as devazepide and tifluadom, however these have not been included in the list below. 2,3-benzodiazepines such as tofisopam ...
This is a list of drugs and substances that are known or suspected to cause Stevens–Johnson syndrome This is a dynamic list and may never be able to satisfy particular standards for completeness. You can help by adding missing items with reliable sources .
Three basic approaches to the taper are using the same medication for tapering, adding adjunctive medication for alleviating withdrawal symptoms, and switching to a longer-acting equivalent. [14] One of the recommended benzodiazepine taper is to reduce the dose by 50% in the first 4 weeks, maintain the dose for 1–2 months, and then reduce the ...
Adverse drug reaction. This could occur when a patient has an allergic response to a medication. [7] Inappropriate adherence. This could occur when a patient chooses not to or forgets to take a medication. [7] Needs additional drug therapy. This could occur when a patient needs more medication to treat their condition. [7]